Taxonomy development for term standardization in activity resulting from medication review processes: a Delphi study

Author:

Alharthi Mohammed S1ORCID,Scott Sion2,Hughes Carmel3ORCID,Bond Christine4ORCID,Hatah Ernieda5,Bryant Linda6,Holland Richard7,Kosari Sam8ORCID,Baqir Wasim9,Loke Yoon10ORCID,Wright David2

Affiliation:

1. Department of Clinical Pharmacy, College of Pharmacy, Taif University , Taif 21947 , Saudi Arabia

2. School of Healthcare, University of Leicester , Leicester, LE1 7RH , United Kingdom

3. School of Pharmacy, Queen’s University Belfast , Belfast, BT7 1NN , United Kingdom

4. Institute of Applied Health Sciences, University of Aberdeen , Aberdeen, AB24 3FX , United Kingdom

5. Faculty of Pharmacy, Universiti Kebangsaan Malaysia , Kuala Lumpur, 43600 , Malaysia

6. Department of General Practice and Primary Health Care, University of Auckland , Auckland, 1010 , New Zealand

7. Exeter Medical School, University of Exeter , Exeter, EX4 4PY , United Kingdom

8. Discipline of Pharmacy, Faculty of Health, University of Canberra , Bruce, 2617 , Australia

9. Northumbria Healthcare NHS Trust and NHS , NE27 0QJ , United Kingdom

10. School of Medicine, Health Policy and Practice, University of East Anglia , Norwich, NR4 7TJ , United Kingdom

Abstract

Abstract Background Medication review (MR) is the systematic assessment of a patient’s medications for safety and effectiveness by a healthcare professional. The language used to describe MR activity, such as stopped medicine and increased dose, should be consistent across studies to assist researchers compare how different services operate and identify their mechanism of impact. Aim To develop an international taxonomy of standardized terms and activity definitions related to medication reviews. Method This was a three-stage Delphi-based consensus study with international medication review experts. A systematic review provided MR activity terms for the survey. Experts rated their consensus on each activity term and its definition on a Likert scale and provided written feedback. The consensus was 75% panel agreement. At each stage, consensus elements were retained, and feedback was used to revise definitions. Results Seven experts were recruited for the study (response rate 15.2%) from four countries: the United Kingdom (n = 4), New Zealand (n = 1), Australia (n = 1), and Malaysia (n = 1). The following terms achieved consensus: the term Medication as a descriptor for MR terms; discontinue medication, start medication, dose increase, dose decrease, dosage form change, and medication safety and efficacy monitor to describe MR activity; Educate to describe the delivery of healthcare professionals and patients/carers education. Conclusion Standardized medication review activity terms and definitions have been selected for universal adoption in all future MR research to facilitate a meaningful comparison of process evaluations within different settings.

Publisher

Oxford University Press (OUP)

Reference19 articles.

1. PCNE definition of medication review: reaching agreement;Griese-Mammen,201

2. Terms used to describe and define activities undertaken as a result of the medication review process: do they require standardisation? A systematic review;Alharthi,2022

3. Clinical medication review by a pharmacist of elderly people living in care homes: pharmacist interventions;Alldred,2010

4. An evaluation of medication review reports across different settings;Freeman,2013

5. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands;Chau,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3